Results 21 to 30 of about 33,608 (178)
Viscerotropic disease and acute uveitis following yellow fever vaccination: a case report
BMC Infectious Diseases, 2020 Background Yellow fever vaccine exists for over 80 years and is considered to be relatively safe. However, in rare cases it can produce serious neurotropic and viscerotropic complications.
Lev Volkov +10 more
doaj +1 more source
Malaria transmission in Africa: Its relationship with yellow fever and measles.
PLoS ONE, 2022 BackgroundMalaria has been strongly linked to the transmission and pathophysiology of some viral diseases. Malaria and vaccine-preventable diseases often co-exist in endemic countries but the implication of their co-existence on their transmission ...
Oluyemi A Okunlola, Oyetunde T Oyeyemi
doaj +1 more source
Molecular Therapy: Methods & Clinical Development, 2022 New platforms are needed for the design of novel prophylactic vaccines and advanced immune therapies. Live-attenuated yellow fever vaccine YF17D serves as a vector for several licensed vaccines and platform for novel candidates. On the basis of YF17D, we
Li-Hsin Li +12 more
doaj +1 more source
Serious adverse event: late neurotropic disease associated with yellow fever vaccine
Einstein (São Paulo), 2020 The yellow fever is a systemic disease that was under control due to the effective campaigns against the vector and promotion of vaccines programs. However, since 1999, outbreaks appeared because of inefficient control of the vector, and led to the need ...
Henrique Souza Barros de Oliveira +5 more
doaj +2 more sources
Emerging Infectious Diseases, 2022 Ghana is a yellow fever–endemic country and experienced a vaccine-derived polio outbreak in July 2019. A reactive polio vaccination campaign was conducted in September 2019 and preventive yellow fever campaign in November 2020.
Kwame Amponsa-Achiano +4 more
doaj +1 more source
Intradermally administered yellow fever vaccine at reduced dose induces a protective immune response: a randomized controlled non-inferiority trial. [PDF]
PLoS ONE, 2008 Implementation of yellow fever vaccination is currently hampered by limited supply of vaccine. An alternative route of administration with reduced amounts of vaccine but without loss of vaccine efficacy would boost vaccination programmes.A randomized ...
Anna H Roukens +4 more
doaj +1 more source
Visualization of yellow fever virus infection in mice using a bioluminescent reporter virus
Emerging Microbes and Infections, 2021 Yellow fever virus (YFV) is a re-emerging flavivirus, which can lead to severe clinical manifestations and high mortality, with no specific antiviral therapies available.
Hao-Long Dong +9 more
doaj +1 more source
Vaccines, 2019 Yellow fever is a potentially fatal, mosquito-borne viral disease that appears to be experiencing a resurgence in endemic areas in Africa and South America and spreading to non-endemic areas despite an effective vaccine.
Kay M. Tomashek +3 more
doaj +1 more source
Yellow Fever Virus Vaccine–associated Deaths in Young Women
Emerging Infectious Diseases, 2011 Yellow fever vaccine–associated viscerotropic disease is a rare sequela of live-attenuated virus vaccine. Elderly persons and persons who have had thymectomies have increased susceptibility.
Stephen J. Seligman
doaj +1 more source
An Atypical Local Vesicular Reaction to the Yellow Fever Vaccine
Vaccines, 2017 Yellow fever vaccine is a live attenuated viral inoculation indicated for patients traveling to endemic areas. The vaccine is generally well tolerated with minimal adverse effects.
Robert H. Wauters +2 more
doaj +1 more source